Upadacitinib for moderate to severe atopic dermatitis with generalized prurigo nodularis

被引：0
作者：
Lou, Fanglu [1 ,2 ,3 ,4 ]
Wang, Yuyi [1 ,2 ,3 ,4 ]
Xiao, Yujuan [1 ,2 ,3 ,4 ]
Liu, Yi [1 ,2 ,3 ,4 ]
机构：
[1] Chongqing Coll Tradit Chinese Med, Affiliated Hosp 1, Dept Dermatol, Chongqing 400011, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Dermatol, 40 Daomenkou St, Chongqing 400011, Peoples R China
[3] Chongqing Key Lab Integrat Dermatol Res, Chongqing, Peoples R China
[4] Chongqing Clin Res Ctr Dermatol, Chongqing, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 07期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.asjsur.2024.02.127
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：3084 / 3088
页数：5
相关论文
共 50 条
  • [31] Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis
    Hagino, Teppei
    Yoshida, Mai
    Hamada, Risa
    Fujimoto, Eita
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2023, 50 (12) : 1576 - 1584
  • [32] Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study
    Yang, Yan
    Chen, Jiaoquan
    Xiong, Siyin
    Zhang, Jing
    Ye, Qianru
    Xue, Rujun
    Tian, Xin
    Zhong, Jiemin
    Zhu, Huilan
    Gao, Aili
    Liu, Yumei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [33] Treatment With Upadacitinib in Refractory Prurigo Nodularis: A Prospective Cohort Study
    Lee, Jungsoo
    Kim, Youngbeom
    Shin, Kihyuk
    Kim, Hoon-Soo
    Ko, Hyun-Chang
    Kim, Moon-Bum
    Kim, Byung-Soo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (05) : 546 - 554
  • [34] Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Fujimoto, Eita
    Saeki, Hidehisa
    Kanda, Naoko
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3201 - 3212
  • [35] Atopic prurigo nodularis responds to intravenous immunoglobulins
    Feldmeyer, L.
    Werner, S.
    Kamarashev, J.
    French, L. E.
    Hofbauer, G. F. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) : 461 - 462
  • [36] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2022, 49 (11) : 1158 - 1167
  • [37] Dupilumab Treatment for Generalized Prurigo Nodularis
    Beck, Kristen M.
    Yang, Eric J.
    Sekhon, Sahil
    Bhutani, Tina
    Liao, Wilson
    JAMA DERMATOLOGY, 2019, 155 (01) : 118 - 120
  • [38] Using the EMD Protocol for Urge to reduce scratching behavior in patients with atopic dermatitis and prurigo nodularis
    Mathijs, R. De Veer
    Waalboer-Spuij, Rick
    Hijnen, Dirk Jan
    Doeksen, Do
    Busschbach, Jan J.
    Nijsten, Tamar E. C.
    Kranenburg, Leonieke W.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2024, 181
  • [39] Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
    Deng, Junwen
    Parthasarathy, Varsha
    Marani, Melika
    Bordeaux, Zachary
    Lee, Kevin
    Trinh, Chi
    Cornman, Hannah L.
    Kambala, Anusha
    Pritchard, Thomas
    Chen, Shihua
    Sutaria, Nishadh
    Oladipo, Olusola O.
    Kwatra, Madan M.
    Alphonse, Martin P.
    Kwatra, Shawn G.
    FRONTIERS IN MEDICINE, 2022, 9
  • [40] Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis
    Gargiulo, L.
    Ibba, L.
    Fiorillo, G.
    Valenti, M.
    Sierzputowska, P.
    Costanzo, A.
    Narcisi, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (03) : e252 - e253
12345